EBRO 2017

Prophylactic extended field RT

• Which patients? – PET-CT (sensitivity 84%, specificity 95%) – RPLND • EMBRACE II criteria – Common iliac node or ≥ 3 pelvic nodes – Treat to renal vein (PA nodes above renal vessels incurable)